DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Kantarjian H, Fenaux P, Sekeres MA. et al.
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
J Clin Oncol 2010;
28 (03) 437-444
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.